EpiVax's Grant - VI Round

EpiVax raised a round of funding on September 17, 2004. Investors include U.S. Department of Health and Human Services.

EpiVax, is a privately held biotechnology company focused on the development of vaccines and immunotherapies for infectious diseases, autoimmunity and cancer. The immunoinformatics team at EpiVax has …

Articles about EpiVax's Grant - VI Round: